Bill > HB1045

This bill modifies the circumstances under which prescription monitoring data, which is confidential information about controlled substance prescriptions, can be shared with federal law enforcement agencies. Previously, such data could be disclosed to federal agencies upon receiving a subpoena for an investigation. However, this bill adds a crucial limitation: if the Protected Health Care Commission, a body established to identify sensitive health services information, determines that the prescription monitoring data is considered "sensitive health services information" and the Secretary of Health has designated it as "legally protected health care," then disclosure to a federal law enforcement agency, even with a subpoena, is prohibited. This change aims to protect certain sensitive health information from being accessed by federal authorities under specific circumstances, ensuring greater privacy for individuals receiving care related to these services.